Australia markets close in 3 hours 53 minutes

Reshape Lifesciences Inc (24O0.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
18.100.00 (0.00%)
At close: 05:36PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
8,335
8,678
11,240
13,600
11,299
-
Cost of revenue
2,846
3,130
4,438
5,252
5,037
-
Gross profit
5,489
5,548
6,802
8,348
6,262
-
Operating expenses
Research development
2,346
2,315
2,537
2,369
3,498
-
Selling general and administrative
14,361
17,872
31,343
33,212
15,221
-
Total operating expenses
16,707
20,187
33,880
35,581
18,719
-
Operating income or loss
-11,218
-14,639
-27,078
-27,233
-12,457
-
Interest expense
-
-
113
832
2,049
451
Total other income/expenses net
312
3,278
-19,403
-35,355
-7,305
-
Income before tax
-10,866
-11,335
-46,594
-63,420
-21,811
-
Income tax expense
52
52
-380
-274
-181
-
Income from continuing operations
-10,918
-11,387
-46,214
-63,146
-21,630
-
Net income
-10,918
-11,387
-46,214
-63,146
-21,630
-
Net income available to common shareholders
-10,918
-11,387
-46,214
-63,146
-21,630
-
Basic EPS
-38.56
-1.91
-108.90
-288.97
-277.00
-
Diluted EPS
-38.56
-1.91
-108.90
-288.97
-277.00
-
Basic average shares
2,229
5,957
424.39
218.522
78.095
-
Diluted average shares
2,229
5,957
424.39
218.522
78.095
-